Canadian Biopharm Company Opens Cleanrooms, Fermentor

May 11, 2001 – MONTREAL — DSM Biologics has opened a new 530-gallon fermentation unit that consists of two cleanrooms and a fermentor train at its Montreal site for the preparation of biopharmaceuticals based on cell cultures.

The fermentor train consists of two seed fermentors of 13 gallons and 85 gallons.

DSM Biologics is an offshoot of DSM Fine Chemicals business group. The DSM Biologics site in Montreal is jointly owned by DSM and SocietDe gDenDerale de financement du QuDebec, according to the Canada NewsWire service.

The $5.82 million unit meets the quality standards set by the pharmaceutical industry (cGMP).

According to officials at the grand opening ceremony, current global capacity for pharmaceutical contract manufacturing will not meet future demand. Over the next five years, the market is expected to grow to to just under $194 million.

“Today’s inauguration illustrates the extent to which investments -such as the one by SGF – play an essential role in allowing partnering companies to conquer international markets,” Francis Bellido, president and CEO of SGF Health was quoted as saying.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.